PharmaEssentia Shares Surge to Limit Up on Anticipated US Drug Approval

cnyes · 2026-08-05T03:45:33+00:00

PharmaEssentia shares hit the daily limit as investors anticipate the upcoming August 30 FDA decision for its ET treatment drug, Ropeg, cementing its lead in biotech.